LeonaBio Capital Expenditures (CapEx) Growth & History (LONA)

LeonaBio's capital expenditures (capex) was $33,000 for fiscal 2024.

View full LeonaBio company overview

LeonaBio annual capital expenditures (capex) history

LeonaBio annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$33,000−$271,000−89.14%
20232023-12-31$304,000−$837,000−73.36%
20222022-12-31$1.1M−$432,000−27.46%
20212021-12-31$1.6M−$747,000−32.20%
20202020-12-31$2.3M

LeonaBio capital expenditures (capex) trends

Between the periods ended 2020-12-31 and 2024-12-31, LeonaBio's capital expenditures (capex) decreased from $2.3M to $33,000, a change of −$2.3M. The latest reported quarter, Q4 2024, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review LeonaBio source filings ↗

Community posts

It’s quiet here.

No posts about LONA yet. Start the conversation.

Write the first post